{"id":186884,"date":"2025-04-15T23:02:30","date_gmt":"2025-04-15T23:02:30","guid":{"rendered":"https:\/\/peraltafinancing.com\/business\/finance\/why-pfizer-stock-topped-the-market-on-tuesday\/"},"modified":"2025-04-15T23:02:30","modified_gmt":"2025-04-15T23:02:30","slug":"why-pfizer-stock-topped-the-market-on-tuesday","status":"publish","type":"post","link":"https:\/\/fivemor.com\/?p=186884","title":{"rendered":"Why Pfizer Stock Topped the Market on Tuesday"},"content":{"rendered":"<p> <br \/>\n<\/p>\n<div>\n<p>On Tuesday, investors continued to snap up shares of big pharmaceutical company <strong>Pfizer<\/strong> <span class=\"font-bold whitespace-nowrap\" data-id=\"204972\">(<a class=\"ticker-symbol\" href=\"https:\/\/www.fool.com\/quote\/nyse\/pfe\/\">PFE<\/a><span class=\"text-green-900 ticker-change\"> 1.51%<\/span>)<\/span>. Somewhat counterintuitively, this week&#8217;s rise came after the company announced it was ending the development of a drug in a very hot product category. On Tuesday, Pfizer&#8217;s stock closed the day 1.5% higher, providing a pleasant contrast to the <strong>S&amp;P 500<\/strong> index&#8217;s 0.2% dip.<\/p>\n<h2>Weight loss drug not a loss<\/h2>\n<p>Tuesday was a relatively uneventful news day for Pfizer, especially following the <a href=\"https:\/\/www.fool.com\/investing\/stock-market\/market-sectors\/healthcare\/pharmaceutical-stocks\/\" title=\"https:\/\/www.fool.com\/investing\/stock-market\/market-sectors\/healthcare\/pharmaceutical-stocks\/ Shift+Click to open\">pharmaceutical<\/a> giant&#8217;s disclosure on Monday that it halted the development of its investigational weight loss drug <a href=\"https:\/\/www.fool.com\/investing\/2025\/04\/15\/is-pfizer-still-a-buy-after-scrapping-its-weight-l\/\">danuglipron<\/a>. This occurred after a patient suffered a liver injury during the testing of the medication. <\/p>\n<p>Yet Pfizer watchers are well aware that the large and well-resourced company doesn&#8217;t only have one pony in the race. It has a different treatment in its pipeline, PF-07976016, that&#8217;s based on a different mechanism and is currently undergoing phase 2 clinical trials.<\/p>\n<p>One analyst tracking the pharmaceutical stock didn&#8217;t hesitate to point in a new research note published Tuesday morning that the company still has options. Bernstein SocGen&#8217;s Courtney Breen wrote in her analysis, according to reports, that Pfizer will likely turn to its tried-and-true strategy of building up its pipeline with mergers and acquisitions, and\/or licensing of products developed by peers. <\/p>\n<h2>Waiting for new success<\/h2>\n<p>Investors can be quite a hardy bunch, and collectively they seem to be shrugging off what many would consider a major setback in the lab with danuglipron. That being said, it is a setback, and Pfizer hasn&#8217;t been a pharmaceutical pace-setter since the days of its Comirnaty vaccine during the coronavirus pandemic. The market is likely to start getting more impatient with the company soon.<\/p>\n<\/p><\/div>\n<div>\n            <span class=\"article-disclosure\"><\/p>\n<p><em><a href=\"https:\/\/www.fool.com\/author\/4067\/\">Eric Volkman<\/a> has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Pfizer. The Motley Fool has a <a href=\"https:\/\/www.fool.com\/legal\/fool-disclosure-policy\/\">disclosure policy<\/a>.<\/em><\/p>\n<p><\/span>\n          <\/div>\n\n","protected":false},"excerpt":{"rendered":"<p>On Tuesday, investors continued to snap up shares of big pharmaceutical company Pfizer (PFE 1.51%). Somewhat counterintuitively, this week&#8217;s rise came after the company announced it was ending the development of a drug in a very hot product category. On Tuesday, Pfizer&#8217;s stock closed the day 1.5% higher, providing a pleasant contrast to the S&amp;P [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":186885,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[93],"tags":[11209,29323,3310,10483,18125],"dealstore":[],"offerexpiration":[],"class_list":["post-186884","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-finance","tag-market","tag-pfizer","tag-stock","tag-topped","tag-tuesday"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Why Pfizer Stock Topped the Market on Tuesday - Som2ny Network<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fivemor.com\/?p=186884\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Why Pfizer Stock Topped the Market on Tuesday - Som2ny Network\" \/>\n<meta property=\"og:description\" content=\"On Tuesday, investors continued to snap up shares of big pharmaceutical company Pfizer (PFE 1.51%). Somewhat counterintuitively, this week&#8217;s rise came after the company announced it was ending the development of a drug in a very hot product category. On Tuesday, Pfizer&#8217;s stock closed the day 1.5% higher, providing a pleasant contrast to the S&amp;P [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fivemor.com\/?p=186884\" \/>\n<meta property=\"og:site_name\" content=\"Som2ny Network\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-15T23:02:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/fivemor.com\/wp-content\/uploads\/2025\/04\/two-people-in-white-lab-coats-looking-at-a-computer-display-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1440\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/fivemor.com\/?p=186884#article\",\"isPartOf\":{\"@id\":\"https:\/\/fivemor.com\/?p=186884\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/fivemor.com\/#\/schema\/person\/b85e3c3dc0e1daea076524dc8810c371\"},\"headline\":\"Why Pfizer Stock Topped the Market on Tuesday\",\"datePublished\":\"2025-04-15T23:02:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/fivemor.com\/?p=186884\"},\"wordCount\":325,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/fivemor.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/fivemor.com\/?p=186884#primaryimage\"},\"thumbnailUrl\":\"https:\/\/fivemor.com\/wp-content\/uploads\/2025\/04\/two-people-in-white-lab-coats-looking-at-a-computer-display-scaled.jpg\",\"keywords\":[\"Market\",\"Pfizer\",\"STOCK\",\"Topped\",\"Tuesday\"],\"articleSection\":[\"Finance\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/fivemor.com\/?p=186884#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/fivemor.com\/?p=186884\",\"url\":\"https:\/\/fivemor.com\/?p=186884\",\"name\":\"Why Pfizer Stock Topped the Market on Tuesday - Som2ny Network\",\"isPartOf\":{\"@id\":\"https:\/\/fivemor.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/fivemor.com\/?p=186884#primaryimage\"},\"image\":{\"@id\":\"https:\/\/fivemor.com\/?p=186884#primaryimage\"},\"thumbnailUrl\":\"https:\/\/fivemor.com\/wp-content\/uploads\/2025\/04\/two-people-in-white-lab-coats-looking-at-a-computer-display-scaled.jpg\",\"datePublished\":\"2025-04-15T23:02:30+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/fivemor.com\/?p=186884#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/fivemor.com\/?p=186884\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/fivemor.com\/?p=186884#primaryimage\",\"url\":\"https:\/\/fivemor.com\/wp-content\/uploads\/2025\/04\/two-people-in-white-lab-coats-looking-at-a-computer-display-scaled.jpg\",\"contentUrl\":\"https:\/\/fivemor.com\/wp-content\/uploads\/2025\/04\/two-people-in-white-lab-coats-looking-at-a-computer-display-scaled.jpg\",\"width\":2560,\"height\":1440},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/fivemor.com\/?p=186884#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/fivemor.com\/?bp_activities=1\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Why Pfizer Stock Topped the Market on Tuesday\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/fivemor.com\/#website\",\"url\":\"https:\/\/fivemor.com\/\",\"name\":\"Som2ny Network\",\"description\":\"Daily Deals\",\"publisher\":{\"@id\":\"https:\/\/fivemor.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/fivemor.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/fivemor.com\/#organization\",\"name\":\"Som2ny Network\",\"url\":\"https:\/\/fivemor.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/fivemor.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/fivemor.com\/wp-content\/uploads\/2026\/07\/4a0953c4-logo-300x86-1.png\",\"contentUrl\":\"https:\/\/fivemor.com\/wp-content\/uploads\/2026\/07\/4a0953c4-logo-300x86-1.png\",\"width\":300,\"height\":86,\"caption\":\"Som2ny Network\"},\"image\":{\"@id\":\"https:\/\/fivemor.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/fivemor.com\/#\/schema\/person\/b85e3c3dc0e1daea076524dc8810c371\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/fivemor.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/729ae85bf62b9917e93538db2f2688ca?s=96&r=g&default=https%3A%2F%2Ffivemor.com%2Fwp-content%2Fplugins%2Fbuddypress-first-letter-avatar%2Fimages%2Fdefault%2F96%2Flatin_a.png\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/729ae85bf62b9917e93538db2f2688ca?s=96&r=g&default=https%3A%2F%2Ffivemor.com%2Fwp-content%2Fplugins%2Fbuddypress-first-letter-avatar%2Fimages%2Fdefault%2F96%2Flatin_a.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/fivemor.com\"],\"url\":\"https:\/\/fivemor.com\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Why Pfizer Stock Topped the Market on Tuesday - Som2ny Network","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fivemor.com\/?p=186884","og_locale":"en_US","og_type":"article","og_title":"Why Pfizer Stock Topped the Market on Tuesday - Som2ny Network","og_description":"On Tuesday, investors continued to snap up shares of big pharmaceutical company Pfizer (PFE 1.51%). Somewhat counterintuitively, this week&#8217;s rise came after the company announced it was ending the development of a drug in a very hot product category. On Tuesday, Pfizer&#8217;s stock closed the day 1.5% higher, providing a pleasant contrast to the S&amp;P [&hellip;]","og_url":"https:\/\/fivemor.com\/?p=186884","og_site_name":"Som2ny Network","article_published_time":"2025-04-15T23:02:30+00:00","og_image":[{"width":2560,"height":1440,"url":"https:\/\/fivemor.com\/wp-content\/uploads\/2025\/04\/two-people-in-white-lab-coats-looking-at-a-computer-display-scaled.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/fivemor.com\/?p=186884#article","isPartOf":{"@id":"https:\/\/fivemor.com\/?p=186884"},"author":{"name":"admin","@id":"https:\/\/fivemor.com\/#\/schema\/person\/b85e3c3dc0e1daea076524dc8810c371"},"headline":"Why Pfizer Stock Topped the Market on Tuesday","datePublished":"2025-04-15T23:02:30+00:00","mainEntityOfPage":{"@id":"https:\/\/fivemor.com\/?p=186884"},"wordCount":325,"commentCount":0,"publisher":{"@id":"https:\/\/fivemor.com\/#organization"},"image":{"@id":"https:\/\/fivemor.com\/?p=186884#primaryimage"},"thumbnailUrl":"https:\/\/fivemor.com\/wp-content\/uploads\/2025\/04\/two-people-in-white-lab-coats-looking-at-a-computer-display-scaled.jpg","keywords":["Market","Pfizer","STOCK","Topped","Tuesday"],"articleSection":["Finance"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/fivemor.com\/?p=186884#respond"]}]},{"@type":"WebPage","@id":"https:\/\/fivemor.com\/?p=186884","url":"https:\/\/fivemor.com\/?p=186884","name":"Why Pfizer Stock Topped the Market on Tuesday - Som2ny Network","isPartOf":{"@id":"https:\/\/fivemor.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/fivemor.com\/?p=186884#primaryimage"},"image":{"@id":"https:\/\/fivemor.com\/?p=186884#primaryimage"},"thumbnailUrl":"https:\/\/fivemor.com\/wp-content\/uploads\/2025\/04\/two-people-in-white-lab-coats-looking-at-a-computer-display-scaled.jpg","datePublished":"2025-04-15T23:02:30+00:00","breadcrumb":{"@id":"https:\/\/fivemor.com\/?p=186884#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fivemor.com\/?p=186884"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/fivemor.com\/?p=186884#primaryimage","url":"https:\/\/fivemor.com\/wp-content\/uploads\/2025\/04\/two-people-in-white-lab-coats-looking-at-a-computer-display-scaled.jpg","contentUrl":"https:\/\/fivemor.com\/wp-content\/uploads\/2025\/04\/two-people-in-white-lab-coats-looking-at-a-computer-display-scaled.jpg","width":2560,"height":1440},{"@type":"BreadcrumbList","@id":"https:\/\/fivemor.com\/?p=186884#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/fivemor.com\/?bp_activities=1"},{"@type":"ListItem","position":2,"name":"Why Pfizer Stock Topped the Market on Tuesday"}]},{"@type":"WebSite","@id":"https:\/\/fivemor.com\/#website","url":"https:\/\/fivemor.com\/","name":"Som2ny Network","description":"Daily Deals","publisher":{"@id":"https:\/\/fivemor.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fivemor.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/fivemor.com\/#organization","name":"Som2ny Network","url":"https:\/\/fivemor.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/fivemor.com\/#\/schema\/logo\/image\/","url":"https:\/\/fivemor.com\/wp-content\/uploads\/2026\/07\/4a0953c4-logo-300x86-1.png","contentUrl":"https:\/\/fivemor.com\/wp-content\/uploads\/2026\/07\/4a0953c4-logo-300x86-1.png","width":300,"height":86,"caption":"Som2ny Network"},"image":{"@id":"https:\/\/fivemor.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/fivemor.com\/#\/schema\/person\/b85e3c3dc0e1daea076524dc8810c371","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/fivemor.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/729ae85bf62b9917e93538db2f2688ca?s=96&r=g&default=https%3A%2F%2Ffivemor.com%2Fwp-content%2Fplugins%2Fbuddypress-first-letter-avatar%2Fimages%2Fdefault%2F96%2Flatin_a.png","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/729ae85bf62b9917e93538db2f2688ca?s=96&r=g&default=https%3A%2F%2Ffivemor.com%2Fwp-content%2Fplugins%2Fbuddypress-first-letter-avatar%2Fimages%2Fdefault%2F96%2Flatin_a.png","caption":"admin"},"sameAs":["https:\/\/fivemor.com"],"url":"https:\/\/fivemor.com\/?author=1"}]}},"_links":{"self":[{"href":"https:\/\/fivemor.com\/index.php?rest_route=\/wp\/v2\/posts\/186884","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fivemor.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fivemor.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fivemor.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/fivemor.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=186884"}],"version-history":[{"count":0,"href":"https:\/\/fivemor.com\/index.php?rest_route=\/wp\/v2\/posts\/186884\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fivemor.com\/index.php?rest_route=\/wp\/v2\/media\/186885"}],"wp:attachment":[{"href":"https:\/\/fivemor.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=186884"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fivemor.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=186884"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fivemor.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=186884"},{"taxonomy":"dealstore","embeddable":true,"href":"https:\/\/fivemor.com\/index.php?rest_route=%2Fwp%2Fv2%2Fdealstore&post=186884"},{"taxonomy":"offerexpiration","embeddable":true,"href":"https:\/\/fivemor.com\/index.php?rest_route=%2Fwp%2Fv2%2Fofferexpiration&post=186884"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}